Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 USD | +5.66% | +5.00% | +21.30% |
14/05 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
James V. Caruso
CEO | Chief Executive Officer | 65 | 15/15/15 |
Chad J. Kolean
DFI | Director of Finance/CFO | 59 | 28/14/28 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15/23/15 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15/16/15 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21/22/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 07/17/07 |
Douglas Swirsky
CHM | Chairman | 54 | 07/17/07 |
John Neis
BRD | Director/Board Member | 68 | 01/08/01 |
James V. Caruso
CEO | Chief Executive Officer | 65 | 15/15/15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15/15/15 |
Director/Board Member | 55 | 24/21/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 320 | 0 | 0 | 88.19 % |
Stock B | 0 | 111 | 0 | 0 | |
Stock C | 0 | 1,237 | 0 | 0 | |
Stock D | 1 | 32,260,510 | 28,450,306 ( 88.19 %) | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.30% | 12Cr | |
+35.01% | 71TCr | |
+30.53% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.55% | 24TCr | |
+9.34% | 21TCr | |
-3.76% | 20TCr | |
+10.77% | 17TCr |
- Stock Market
- Equities
- CLRB Stock
- Company Cellectar Biosciences, Inc.